Condition
RAD51D Gene Mutation
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 2 (1)
Trial Status
Recruiting2
Suspended1
Active Not Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT02993068Not ApplicableSuspended
Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible)
NCT05420064Not ApplicableRecruiting
An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results
NCT04294927Not ApplicableRecruiting
TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
NCT06033092Phase 2Active Not Recruiting
Low Dose TamOxifen and LifestylE Changes for bReast cANcer prevenTion
Showing all 4 trials